Pfizer Interested in Purchasing Seagen for $30 Billion
Biotech company Seagen, which focuses on cancer treatments, could soon have a new owner even after the failed sale to pharmaceutical giant Merck. According to the Wall Street Journal, Pfizer, one of the world’s leading pharma companies, engaged in early talks about the Seagen...
Merck Closing in on $40 Billion Acquisition of Biotech Company Seagen
American multinational pharmaceutical company Merck & Co. is reportedly inching closer to the acquisition of biotech company Seagen. According to Wall Street Journal, the deal could be worth around $40 billion.
The two companies are still having active discussions but are reportedly close to settling...